Related Experiment Video
Updated: Aug 2, 2025
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Roflumilast enhances the melanogenesis and attenuates oxidative stress-triggered damage in melanocytes
Zile Chen1, Yiting Li1, Yongyi Xie1
1Department of Dermatology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background:
The management of vitiligo is challenging due to limited treatment options, and therapeutic strategy varies according to the active or stable stage of vitiligo. PDE4 inhibitor has been used to treat various skin diseases, but the efficacy in vitiligo treatment is mixed.
Objective:
In this study, we aimed to investigate whether roflumilast, a PDE4 inhibitor, induces melanogenesis and attenuates oxidative stress-triggered damage in melanocytes, and if so, what is the mechanism.
Methods:
Melanin content assay, qRT-PCR, western blotting, ELISA, immunofluorescence assays, immunohistochemistry, small interfering RNA, flow cytometry, and transmission electron microscopy were employed.
Results:
Our results demonstrated that roflumilast alone only slightly increased melanogenesis, however, the combination of roflumilast and forskolin could boost cAMP levels, hence promoting melanogenesis more significantly. Moreover, roflumilast attenuated H2O2-induced apoptosis and mitochondrial morphological changes in melanocytes by reducing ROS levels. Furthermore, roflumilast activated AhR/Nrf2 pathway via cAMP whereas AhR silencing blocked roflumilast-induced Nrf2 nuclear translocation and reversed the inhibitory effect of roflumilast on H2O2-induced ROS production. Finally, we observed that the lesional skin of active vitiligo patients exhibited higher PDE4 expression levels.
Conclusion:
roflumilast enhances the melanogenesis effect of forskolin and protects melanocytes from H2O2-induced apoptosis by cAMP/AhR/Nrf2-activated ROS inhibition, highlighting its therapeutic potential in vitiligo treatment.
Insights
Roflumilast, a PDE4 inhibitor, enhances melanogenesis and protects melanocytes from oxidative stress. This study highlights its potential therapeutic role in vitiligo management by activating the cAMP/AhR/Nrf2 pathway.
Area of Science:
- Dermatology
- Molecular Biology
- Cell Biology
Background:
- Vitiligo management is challenging due to limited treatment options.
- Phosphodiesterase 4 (PDE4) inhibitors show mixed efficacy in vitiligo treatment.
Purpose of the Study:
- To investigate if roflumilast (a PDE4 inhibitor) induces melanogenesis and protects melanocytes from oxidative stress.
- To elucidate the underlying molecular mechanisms, including the cAMP/AhR/Nrf2 pathway.
Main Methods:
- Melanin content assay, qRT-PCR, western blotting, ELISA, immunofluorescence, immunohistochemistry.
- Small interfering RNA (siRNA), flow cytometry, and transmission electron microscopy were utilized.
- Cellular assays were performed using melanocytes and H2O2-induced oxidative stress models.
Main Results:
- Roflumilast combined with forskolin significantly boosted cAMP levels and promoted melanogenesis.
- Roflumilast reduced reactive oxygen species (ROS) levels, attenuating apoptosis and mitochondrial damage in melanocytes.
- Roflumilast activated the cAMP/AhR/Nrf2 pathway, which was crucial for its protective effects against oxidative stress.
Conclusions:
- Roflumilast enhances forskolin-induced melanogenesis and protects melanocytes from oxidative damage.
- The therapeutic potential of roflumilast in vitiligo is linked to its ability to inhibit ROS via the cAMP/AhR/Nrf2 pathway.
- Elevated PDE4 expression was observed in active vitiligo lesions, suggesting its involvement in disease pathogenesis.
Related Concept Videos
01:19Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms: